Blogroll
-
Join 3 other subscribers
2011 Vaccine Conferences
- 24 – 26 January, 2011: Phacilitate Vaccine Forum, Washington, D.C., USA
- 27 – 30 January, 2011: Controversies in Vaccination in Adults (CoVAC), Berlin, DE
- 10 – 11 February, 2011: Vaccine Research & Innovation 2011, London, UK
- 24 – 25 February, 2011: Next Generation Vaccines, Vienna, AT
- 14 – 18 March, 2011: Biopharmaceutical Development and Production Week, Bellevue, WA, USA
- 23 – 25 March, 2011: BIT’s 3rd Annual World Vaccine Congress, Beijing, CN
- 18 – 21 May, 2011: American Society of Gene and Cell Therapy, Seattle, WA, USA
- 6 – 8 June, 2011: Vaccine Production Summit, Boston, MA, USA
- 27 – 30 June, 2011: BIO International Convention, Washington, D.C., USA
- 12 – 14 July, 2011: DNA Vaccines 2011, San Diego, CA, USA
- 31 October – 4 November, 2011: BioProcess International, Long Beach, CA, USA
Monthly Archives: December 2010
IL-13Rα2 can serve as a potent tumor antigen that can recruit immune responses against IL-13Rα2 expressing solid tumors
This study evaluated prophylactic and therapeutic effects of the IL-13Rα2 cDNA vaccination in syngeneic animal models of melanoma, sarcoma and breast cancer cells expressing IL-13Rα2 to prime the immune system. CTL activity and IFN-γ release was measured in mice vaccinated … Continue reading
Posted in Uncategorized
Leave a comment
VGXI Blog 